BlackRock’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159M | Buy |
|
|||||
|
2025
Q1 | $90.9M | Buy |
|
|||||
|
2024
Q4 | $72.7M | Buy |
|
|||||
|
2024
Q3 | $61.1M | Buy |
|
|||||
|
2024
Q2 | $42.2M | Buy |
|
|||||
|
2024
Q1 | $35.9M | Sell |
|
|||||
|
2023
Q4 | $56M | Sell |
|
|||||
|
2023
Q3 | $63.1M | Buy |
|
|||||
|
2023
Q2 | $77M | Sell |
|
|||||
|
2023
Q1 | $104M | Sell |
|
|||||
|
2022
Q4 | $94.5M | Buy |
|
|||||
|
2022
Q3 | $72.1M | Buy |
|
|||||
|
2022
Q2 | $73M | Buy |
|
|||||
|
2022
Q1 | $82.8M | Buy |
|
|||||
|
2021
Q4 | $153M | Sell |
|
|||||
|
2021
Q3 | $190M | Buy |
|
|||||
|
2021
Q2 | $217M | Buy |
|
|||||
|
2021
Q1 | $197M | Sell |
|
|||||
|
2020
Q4 | $292M | Sell |
|
|||||
|
2020
Q3 | $258M | Sell |
|
|||||
|
2020
Q2 | $272M | Buy |
|
|||||
|
2020
Q1 | $138M | Buy |
|
|||||
|
2019
Q4 | $94.5M | Buy |
|
|||||
|
2019
Q3 | $58.6M | Buy |
|
|||||
|
2019
Q2 | $31.9M | Buy |
|